- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aarti Drugs Limited — Updates, 03-02-2026: Press Release
03-02-2026 | 08:06 pm
03-02-2026 | 08:06 pm
Aarti Drugs reported Q3FY26 revenue of Rs. 602.9 Cr (up 8% YoY) and PAT of Rs. 40.5 Cr (up 58% YoY). EBITDA dipped 10% YoY to Rs. 56.3 Cr due to commissioning costs. New methyl amine plant reached 30% utilization, targeting 100% Metformin self-reliance soon. Salicylic Acid plant also scaled up.
No comments yet. Be the first to comment!